busulfan has been researched along with Cystitis in 33 studies
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Between October 1988 and December 1992, 167 patients with leukemia receiving marrow transplants from HLA-identical donors and conditioned with cyclophosphamide (120 mg/kg) were randomized to additional treatment with either busulfan (16 mg/kg, n = 88) or total body irradiation (TBI; n = 79)." | 9.07 | A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. ( Lenhoff, S; Ljungman, P; Nikoskelainen, J; Parkkali, T; Remberger, M; Ringdén, O; Ruutu, T; Sallerfors, B; Vindeløv, L; Volin, L, 1994) |
| "High dose cyclophosphamide and/or busulfan conditioning treatment of recipients of bone marrow transplants proved to be highly effective but associated with substantial and sometimes life threatening hemorrhagic cystitis." | 7.69 | Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. ( Abella, E; Haas, GP; Karanes, C; Lum, LG; Momin, F; Sensenbrenner, LL; Turkeri, LN; Uberti, JP, 1995) |
| "We report a case of severe hemorrhagic cystitis induced by prolonged busulfan therapy." | 7.66 | Busulfan-induced hemorrhagic cystitis. ( Perlberg, S; Pode, D; Steiner, D, 1983) |
| "A case of a busulfan-induced hemorrhage cystitis is reported." | 7.66 | Busulfan-induced hemorrhagic cystitis. ( Millard, RJ, 1981) |
| "Busulfan-treated patients had an increased risk of veno-occlusive disease (VOD) of the liver (12% v 1%, P =." | 6.69 | Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplanta ( Jacobsen, N; Lenhoff, S; Ljungman, P; Mellander, L; Nikoskelainen, J; Parkkali, T; Remberger, M; Ringdén, O; Ruutu, T; Sallerfors, B; Vindeløv, L; Volin, L, 1999) |
| "Between October 1988 and December 1992, 167 patients with leukemia receiving marrow transplants from HLA-identical donors and conditioned with cyclophosphamide (120 mg/kg) were randomized to additional treatment with either busulfan (16 mg/kg, n = 88) or total body irradiation (TBI; n = 79)." | 5.07 | A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. ( Lenhoff, S; Ljungman, P; Nikoskelainen, J; Parkkali, T; Remberger, M; Ringdén, O; Ruutu, T; Sallerfors, B; Vindeløv, L; Volin, L, 1994) |
| "High dose cyclophosphamide and/or busulfan conditioning treatment of recipients of bone marrow transplants proved to be highly effective but associated with substantial and sometimes life threatening hemorrhagic cystitis." | 3.69 | Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. ( Abella, E; Haas, GP; Karanes, C; Lum, LG; Momin, F; Sensenbrenner, LL; Turkeri, LN; Uberti, JP, 1995) |
| "We report a case of severe hemorrhagic cystitis induced by prolonged busulfan therapy." | 3.66 | Busulfan-induced hemorrhagic cystitis. ( Perlberg, S; Pode, D; Steiner, D, 1983) |
| "A case of a busulfan-induced hemorrhage cystitis is reported." | 3.66 | Busulfan-induced hemorrhagic cystitis. ( Millard, RJ, 1981) |
| "Busulfan-treated patients had an increased risk of veno-occlusive disease (VOD) of the liver (12% v 1%, P =." | 2.69 | Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplanta ( Jacobsen, N; Lenhoff, S; Ljungman, P; Mellander, L; Nikoskelainen, J; Parkkali, T; Remberger, M; Ringdén, O; Ruutu, T; Sallerfors, B; Vindeløv, L; Volin, L, 1999) |
| "To evaluate the toxic extramedullary morbidity of the conditioning treatment with BuCy for BMT, as well as the usefulness of pentoxyphyllin (PTX) and methylprednisolone (MP) in the prophylaxis of mucositis." | 2.39 | [Extramedullary toxicity in bone marrow transplantation using busulfan and cyclophosphamide conditioning]. ( Maldonado, J; Pascual, MJ, 1995) |
| "Mesna possibly has a toxic effect on bladder mucosa." | 1.32 | Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. ( Hattori, K; Hotta, T; Inoue, H; Kato, S; Kawada, H; Kishi, K; Matsumoto, M; Ogawa, Y; Ohmachi, K; Shimizu, T; Tsuboi, K; Watanabe, S; Yabe, H; Yabe, M; Yasuda, Y; Yoshiba, F, 2003) |
| "Haemorrhagic cystitis is a common and often debilitating complication of chemotherapy for which treatment is frequently unsatisfactory." | 1.30 | Hyperbaric oxygen in the treatment of refractory haemorrhagic cystitis. ( Hughes, AJ; Millar, IL; Schwarer, AP, 1998) |
| " Thus, we have developed a safe chemotherapy schedule for transplantation that avoids the need for radiotherapy and can, if necessary, be repeated after a 3-month interval." | 1.27 | Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children. ( Barnes, R; Downie, CJ; Hobbs, JR; Hugh-Jones, K; Shaw, PJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (18.18) | 18.7374 |
| 1990's | 14 (42.42) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 5 (15.15) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Santos Carreira, A | 1 |
| Salas, MQ | 1 |
| Remberger, M | 4 |
| Novitzky-Basso, I | 1 |
| Law, AD | 1 |
| Lam, W | 2 |
| Pasic, I | 1 |
| Mazzulli, T | 1 |
| Cserti-Gazdewich, C | 1 |
| Kim, DDH | 1 |
| Michelis, FV | 2 |
| Viswabandya, A | 1 |
| Gerbitz, A | 1 |
| Lipton, JH | 2 |
| Kumar, R | 1 |
| Hassan, M | 2 |
| Mattsson, J | 2 |
| Törlen, J | 1 |
| Serafi, IE | 1 |
| Garming-Legert, K | 1 |
| Björklund, A | 1 |
| Ljungman, P | 3 |
| Sundin, M | 1 |
| Wang, J | 1 |
| Zhao, J | 1 |
| Fei, X | 1 |
| Yin, Y | 1 |
| Cheng, H | 1 |
| Zhang, W | 1 |
| Gu, J | 1 |
| Yang, F | 1 |
| Yang, Y | 1 |
| Xue, S | 1 |
| Tian, Z | 1 |
| He, J | 1 |
| Zhang, S | 1 |
| Wang, X | 1 |
| Uhm, J | 1 |
| Hamad, N | 1 |
| Shanavas, M | 1 |
| Kuruvilla, J | 1 |
| Gupta, V | 1 |
| Messner, HA | 1 |
| Seftel, M | 1 |
| Kim, DD | 1 |
| Storek, J | 1 |
| Li, H | 1 |
| Geddes, M | 1 |
| Daly, A | 1 |
| Gruhn, B | 1 |
| Klöppner, N | 1 |
| Pfaffendorf-Regler, N | 1 |
| Beck, J | 1 |
| Zintl, F | 1 |
| Bartholomä, S | 1 |
| Debatin, KM | 1 |
| Steinbach, D | 1 |
| Tsuboi, K | 1 |
| Kishi, K | 1 |
| Ohmachi, K | 1 |
| Yasuda, Y | 1 |
| Shimizu, T | 1 |
| Inoue, H | 1 |
| Matsumoto, M | 1 |
| Hattori, K | 1 |
| Yoshiba, F | 1 |
| Watanabe, S | 1 |
| Ogawa, Y | 1 |
| Kawada, H | 1 |
| Yabe, H | 1 |
| Yabe, M | 1 |
| Kato, S | 1 |
| Hotta, T | 1 |
| Yamamoto, R | 1 |
| Kusumi, E | 1 |
| Kami, M | 1 |
| Yuji, K | 1 |
| Hamaki, T | 1 |
| Saito, A | 1 |
| Murasgihe, N | 1 |
| Hori, A | 1 |
| Kim, SW | 1 |
| Makimoto, A | 1 |
| Ueyama, J | 1 |
| Tanosaki, R | 1 |
| Miyakoshi, S | 1 |
| Mori, S | 1 |
| Morinaga, S | 1 |
| Heike, Y | 1 |
| Taniguchi, S | 1 |
| Masuo, S | 1 |
| Takaue, Y | 1 |
| Mutou, Y | 1 |
| Asano, Y | 1 |
| Kanda, Y | 1 |
| Ogawa, N | 1 |
| Sakata-Yanagimoto, M | 1 |
| Nakagawa, M | 1 |
| Kawazu, M | 1 |
| Goyama, S | 1 |
| Kandabashi, K | 1 |
| Izutsu, K | 1 |
| Imai, Y | 1 |
| Hangaishi, A | 1 |
| Kurokawa, M | 1 |
| Tsujino, S | 1 |
| Ogawa, S | 1 |
| Aoki, K | 1 |
| Chiba, S | 1 |
| Motokura, T | 1 |
| Hirai, H | 1 |
| Pode, D | 1 |
| Perlberg, S | 1 |
| Steiner, D | 1 |
| Millard, RJ | 2 |
| Pascual, MJ | 1 |
| Maldonado, J | 1 |
| Klingemann, HG | 1 |
| Shepherd, JD | 1 |
| Reece, DE | 1 |
| Barnett, MJ | 1 |
| Nantel, SH | 1 |
| Sutherland, HJ | 1 |
| Spinelli, JJ | 1 |
| Phillips, GL | 1 |
| Turkeri, LN | 1 |
| Lum, LG | 1 |
| Uberti, JP | 1 |
| Abella, E | 1 |
| Momin, F | 1 |
| Karanes, C | 1 |
| Sensenbrenner, LL | 1 |
| Haas, GP | 1 |
| Ringdén, O | 2 |
| Ruutu, T | 2 |
| Nikoskelainen, J | 2 |
| Volin, L | 2 |
| Vindeløv, L | 2 |
| Parkkali, T | 2 |
| Lenhoff, S | 2 |
| Sallerfors, B | 2 |
| Bernaudin, F | 1 |
| Souillet, G | 1 |
| Vannier, JP | 1 |
| Plouvier, E | 1 |
| Lemerle, S | 1 |
| Michel, G | 1 |
| Bordigoni, P | 1 |
| Lutz, P | 1 |
| Kuentz, M | 1 |
| Erer, B | 1 |
| Angelucci, E | 1 |
| Baronciani, D | 1 |
| Tomasucci, M | 1 |
| Giardini, C | 1 |
| Gaziev, J | 1 |
| Hughes, AJ | 1 |
| Schwarer, AP | 1 |
| Millar, IL | 1 |
| Kondo, M | 1 |
| Kojima, S | 1 |
| Kato, K | 1 |
| Matsuyama, T | 1 |
| Mellander, L | 1 |
| Jacobsen, N | 1 |
| Peinemann, F | 1 |
| de Villiers, EM | 1 |
| Dörries, K | 1 |
| Adams, O | 1 |
| Vögeli, TA | 1 |
| Burdach, S | 1 |
| Ikegame, K | 1 |
| Takimoto, T | 1 |
| Takahashi, R | 1 |
| Murakami, M | 1 |
| Tamaki, H | 1 |
| Fujioka, T | 1 |
| Kawakami, M | 1 |
| Hirabayashi, N | 1 |
| Soma, T | 1 |
| Sugiyama, H | 1 |
| Ogawa, H | 1 |
| Zhu, K | 1 |
| Xu, Y | 1 |
| Wu, D | 1 |
| Xu, X | 1 |
| Huang, L | 1 |
| Leung, AY | 1 |
| Mak, R | 1 |
| Lie, AK | 1 |
| Yuen, KY | 1 |
| Cheng, VC | 1 |
| Liang, R | 1 |
| Kwong, YL | 1 |
| Kasai, M | 1 |
| Kiyama, Y | 1 |
| Watanabe, M | 1 |
| Seto, K | 1 |
| Matsuura, A | 1 |
| Tanaka, J | 1 |
| Takeda, H | 1 |
| Naohara, T | 1 |
| Higa, T | 1 |
| Hashino, S | 1 |
| Flowers, ME | 1 |
| Doney, KC | 1 |
| Storb, R | 1 |
| Deeg, HJ | 1 |
| Sanders, JE | 1 |
| Sullivan, KM | 1 |
| Bryant, E | 1 |
| Witherspoon, RP | 1 |
| Appelbaum, FR | 1 |
| Buckner, CD | 1 |
| Romeiras, M | 1 |
| Rodrigues, AS | 1 |
| Machado, A | 1 |
| Jorge, L | 1 |
| Nolasco, I | 1 |
| Abecasis, M | 1 |
| Morgan, M | 1 |
| Dodds, A | 3 |
| Atkinson, K | 3 |
| Szer, J | 1 |
| Downs, K | 2 |
| Biggs, J | 2 |
| Biggs, JC | 1 |
| Golovsky, D | 1 |
| Concannon, A | 2 |
| Ashby, M | 2 |
| Thomas, AE | 1 |
| Patterson, J | 1 |
| Prentice, HG | 1 |
| Brenner, MK | 1 |
| Ganczakowski, M | 1 |
| Hancock, JF | 1 |
| Pattinson, JK | 1 |
| Blacklock, HA | 1 |
| Hopewell, JP | 1 |
| Shaw, PJ | 1 |
| Hugh-Jones, K | 1 |
| Hobbs, JR | 1 |
| Downie, CJ | 1 |
| Barnes, R | 1 |
| Noble, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Chronic Phase CML[NCT00001144] | Phase 2 | 50 participants | Interventional | 1999-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for busulfan and Cystitis
| Article | Year |
|---|---|
Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.
Topics: Adenoviridae Infections; Adenoviruses, Human; Adolescent; Adult; Aged; Anemia, Aplastic; BK Virus; B | 2003 |
[Extramedullary toxicity in bone marrow transplantation using busulfan and cyclophosphamide conditioning].
Topics: Adolescent; Adult; Anemia, Refractory, with Excess of Blasts; Arrhythmias, Cardiac; Bone Marrow Tran | 1995 |
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Tr | 1994 |
4 trials available for busulfan and Cystitis
26 other studies available for busulfan and Cystitis
| Article | Year |
|---|---|
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation.
Topics: Adult; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cyclosporine; Cystitis; Hematopoietic Stem | 2023 |
Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Allografts; Busulfan; Child; Child, Preschool; Cystitis; Female; Hematopoie | 2017 |
A new intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia.
Topics: Adolescent; Adult; Busulfan; Cyclophosphamide; Cystitis; Cytarabine; Cytomegalovirus Infections; Dru | 2018 |
The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD.
Topics: Adolescent; Adult; Aged; BK Virus; Busulfan; Cystitis; Cytomegalovirus Infections; Female; Graft vs | 2014 |
Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning.
Topics: Antilymphocyte Serum; BK Virus; Busulfan; Case-Control Studies; Cystitis; Disease-Free Survival; Dru | 2017 |
Toll-like 4 receptor variant, Asp299Gly, and reduced risk of hemorrhagic cystitis after hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Busulfan; Child; Child, Preschool; Cystitis; | 2012 |
Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.
Topics: Adolescent; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cystitis; Drug Synergism; Female; Hema | 2003 |
Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST).
Topics: Adenoviridae; Adolescent; Adult; Aged; Antibodies, Viral; Busulfan; Child; Child, Preschool; Cystiti | 2003 |
Busulfan-induced hemorrhagic cystitis.
Topics: Adult; Busulfan; Cystitis; Female; Hemorrhage; Humans; Leukemia, Myeloid; Time Factors; Urinary Blad | 1983 |
Busulfan-induced hemorrhagic cystitis.
Topics: Busulfan; Cystitis; Hemorrhage; Humans; Male; Middle Aged; Urinary Bladder Diseases | 1981 |
Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cystitis; Female; Hemorr | 1995 |
Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMO.
Topics: Adolescent; Africa; Anemia, Sickle Cell; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; | 1993 |
Hemorrhagic cystitis after allogeneic bone marrow transplantation for thalassemia.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Child; Child, Prescho | 1993 |
Hyperbaric oxygen in the treatment of refractory haemorrhagic cystitis.
Topics: Adenoviruses, Human; Adult; Antineoplastic Agents, Alkylating; BK Virus; Busulfan; Cyclophosphamide; | 1998 |
Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children.
Topics: Adolescent; Age Factors; Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclosporine; Cyst | 1998 |
Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants.
Topics: Adolescent; BK Virus; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cystitis; Fema | 2000 |
Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation.
Topics: Adenoviridae Infections; Adenoviruses, Human; Antilymphocyte Serum; Bronchoalveolar Lavage Fluid; Bu | 2001 |
[The toxicity of busulphan and cyclophosphamide as the preparative regimen for allogeneic peripheral blood stem cell transplantation].
Topics: Acute Disease; Adult; Busulfan; Cyclophosphamide; Cystitis; Disease-Free Survival; Esophagitis; Fema | 2000 |
Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation.
Topics: Adenoviridae; Adenoviridae Infections; Adolescent; Adult; Aged; BK Virus; Bone Marrow Transplantatio | 2002 |
Busulphan haemorrhagic cystitis.
Topics: Busulfan; Cystitis; Hematuria; Humans; Leukemia, Myeloid; Male; Middle Aged | 1978 |
Toxicity of high-dose busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cystitis; Dose-Response | 1992 |
Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; | 1992 |
The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cystitis; Drug Therapy, | 1991 |
Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; | 1987 |
Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children.
Topics: Adolescent; Bone Marrow; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosph | 1986 |
Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Cystitis; Hemorrhage; Hepatic Veno-Occlusiv | 1987 |